Olea Sensor Networks CEO to Speak at Telehealth Secrets 2019

RENO, Nev., Sept. 26, 2019 /PRNewswire/ — Frank Morese, CEO and CTO of Olea Sensor Networks, will speak at this year’s Telehealth Secrets Conference in Silicon Valley, October 2-4 addressing the benefits of machine learning diagnostic technologies for medical applications. His topic, Reviving the Family Doctor with AI Technology, will discuss how artificial intelligence is able to mitigate the loss of personalization experienced in today’s medical relationships.   

Olea Sensor Networks, as an industry leader in intelligent sensors and analytic software for sensor network-based systems, will also be on hand on the exhibit floor to demo the OSN Quadcorder for remote health monitoring applications powered by the intelligent software and software analytics capabilities of OleaSense technology. This powerful platform for vital sign monitoring is now available in a new, low cost version, the OleaSense-LX, compatible with all Linux platforms including Raspberry Pi. Unlike claims of some vital sign sensing approaches today, OleaSense can produce clinically accurate vital signs collection and biometric authentication with absolutely no contact with the user. Clinical accuracy has been verified under multiple, strictly monitored, IRB studies.

VSee, Inc., organizers of the Telehealth Secrets conference, anticipate more than 500 attendees this year with past speakers including many health industry leaders, innovators and transformers. This years’ conference promises to inspire and inform. Tickets may be obtained on their website at https://vsee.com/#register.

About Olea

Olea Sensor Networks, incorporated in 2011, develops intelligent sensors and analytic software for advanced “Internet of Things” (IoT) service solutions including a wide variety of applications. Olea specializes in developing non-intrusive sensing technologies and wireless sensor networks including OleaSense, vital sign biometrics technology for advanced safety systems and autonomous driving sensing applications and OleaVision, for Life Presence Detection. Olea technologies and development platforms are offered for non-clinical research and development use, including field trials and testing. Olea is located in Reno, Nevada. For more information go to www.oleasys.com. Follow us on Twitter @OleaSys.

Olea, Olea Sensor Networks, Olea HeartSensor, Olea HeartSignature, OleaSense, OleaVision, BalancedSense, RespiroTrack, IoT Intelligent Partitioning Architecture, OSN Quadcorder, DrowseAlert are trademarks of Olea Systems, Incorporated. Other trademarks (registered or otherwise), names and brands may be claimed as property of Olea Systems, Incorporated or by others.

Contact:
Andrea Morese
(775) 636-7680 
223549@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/olea-sensor-networks-ceo-to-speak-at-telehealth-secrets-2019-300925542.html

SOURCE Olea Sensor Networks

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

3 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

17 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

18 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

18 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

19 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

21 hours ago